AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

AMWL · NYSE · Medical - Healthcare Information Services

Amwell

Enterprise software for embedded hybrid healthcare delivery.

$11.93

After-hours close+0.04 (+0.34%)

At close$11.89(+1.19%)

Something off on this page? Send us feedback.

Profile

American Well CorporationAMWLHealth Care

Enterprise software subscriptions and platform visit fees support a hybrid-care model spanning in-person, virtual, and automated care. The technology is designed to be embedded in healthcare clients' existing offerings and workflows.

Enterprise software supports digital care across clinical, retail, school, and home settings. The platform extends beyond telehealth visits to in-person, virtual, and automated care, and can be embedded in healthcare clients' existing offerings and workflows.

Revenue comes from enterprise software subscriptions and fees for visits run on the enterprise and shared-services platforms. The business also includes an accompanying clinical-services platform. The Converge platform brings products, programs, modules, devices, and third-party applications onto a single code base. The model depends on healthcare clients integrating its technology into their care delivery workflows.

Company facts

CEODr. Ido Schoenberg

ListedSep 17, 2020

ExchangeNYSE

HeadquartersBoston, MA

CountryUnited States

Employees562

CIK0001393584

ISINUS03044L2043

Key statistics

Market cap$202.9M

EPS (ttm)−$4.77

P/E (ttm)−2.50

ROE-33.3%

P/B0.9039

P/S0.9286

Dividend yield—

Beta1.03vs XLV 0.73

Year to date +145% · Average volume (30d) 116.3K

Analysts

Price target, next 12 months$12.50+4.8%Median of 15 analysts · vs the Aug 28 close

ConsensusHold5 of 15 analysts rate it buy or better

Ratings

Strong buyBuyHoldSellStrong sell

Target range

Last close $11.93

High$16.00+34.1%

Median$12.50+4.8%

Low$11.00−7.8%

12 months agoNowIn 12 months

Latest analyst notes

Date	Firm	Action	Rating	Prior target	Target
Aug 13, 2026	Truist Financial	Target		$7.50	$12
Aug 5, 2026	Morgan Stanley	Target		$6.50	$13
Aug 5, 2026	UBS	Target		$10	$11
Jul 17, 2026	Wells Fargo	Reiterate	Overweight		$16
Jun 8, 2026	Truist Financial	Target			$7.50

Earnings

EPS

Estimate−$0.66

ReportedDue Nov 3, 2026

Revenue

Estimate$47.3M

ReportedDue Nov 3, 2026

History

Report date	EPS est	EPS	Surprise	Revenue est	Revenue	Surprise	Next session
Aug 4, 2026Q2 FY26	−$0.86	−$0.59	+31.4%	$49.9M	$52.0M	+4.4%	+24.95%
May 5, 2026Q1 FY26	−$0.77	−$0.78	−1.3%	$51.5M	$54.9M	+6.5%	+12.42%
Feb 12, 2026Q4 FY25	−$1.59	−$1.43	+10.1%	$52.6M	$55.3M	+5.1%	+24.71%
Nov 4, 2025Q3 FY25	−$1.46	−$1.74	−19.4%	$54.6M	$56.3M	+3.2%	−9.50%

View details

Financial highlights

	Q1 FY25	Q2 FY25	Q3 FY25	Q4 FY25	Q1 FY26	Q2 FY26
Revenue	$66.8M	$70.9M	$56.3M	$55.3M	$54.9M	$52.0M
Gross profit	$35.3M	$39.8M	$29.5M	$28.3M	$20.4M	$27.6M
Operating income	−$30.4M	−$20.4M	−$29.3M	−$25.2M	−$12.9M	−$9.6M
Net income	−$18.7M	−$19.7M	−$32.4M	−$24.9M	−$10.9M	−$9.9M
Diluted EPS	−$1.19	−$1.24	−$2.00	−$1.52	−$0.66	−$0.59
Gross margin	52.8%	56.1%	52.4%	51.2%	37.2%	53.0%
Operating margin	-45.5%	-28.7%	-52.1%	-45.5%	-23.6%	-18.4%

Fiscal years (4-quarter sums)FY21 $252.8M · FY22 $277.2M · FY23 $259.0M · FY24 $254.4M · FY25 $249.3M

Revenue by product · Q2 FY26

Platform Subscription$25.7M · 49%

Visits$24.4M · 47%

Others$1.9M · 4%

Balance sheet, Jun 30, 2026Cash & short-term investments $195.9M · Total debt $3.0M · Total assets $327.2M · Shareholders' equity $221.2M

Dividends

No dividends on record.

Ownership

Institutions 37.12%6.31M sharesInsiders 8.13%1.38M sharesOther 54.75%9.31M shares

Shares outstanding 17.01M · Float 13.43M · 79.0% free float

Top shareholders13F · 13D/G · Form 4

Holder	Shares	% outstanding	Form	Filed
Morgan Stanley	1.16M	6.80%	13F	May 15, 2026
Senvest Management, LLC	1.14M	7.60%	13G	May 14, 2026
Cable Car Capital LLC	1.00M	5.89%	13F	May 15, 2026
Funicular Funds, LP	810.6K	5.50%	13G	Jan 26, 2026
Vanguard Capital Management LLC	567.3K	3.34%	13F	May 15, 2026

Insider tradesForm 4

Date	Insider	Role	Shares	Avg price
Jul 1, 2026	Phyllis Gotlib	officer: President, International	−6,677	$9.33
Jul 1, 2026	Dmitry Zamansky	officer: Chief Product & Tech. Officer	−8,460	$9.33
Jul 1, 2026	Mark Hirschhorn	officer: Chief Financial Officer	−4,299	$9.33
Jul 1, 2026	Paul Francis McNeice	officer: Chief Accounting Officer	−653	$9.33
Jun 11, 2026	Stephen J. Schlegel	director	−9,750	$8.76